Submits two new strains for EPA approval
(FMC) — FMC Corporation has announced the submission of two new active ingredient microbial pesticide strains, RTI 301 and RTI 477, and associated formulated products to the EPA Office of Pesticide Programs Biopesticides and Pollution Prevention Division (BPPD). Submissions have also been made in the EU and field work is continuing in Canada as well as countries in Latin America and Asia Pacific.
This unique combination of two bacilli strains offers a new option for growers to suppress some difficult to control and yield robbing diseases such as Sudden Death Syndrome (SDS) in soybeans as well as Fusarium, Rhizoctonia and Phytophthora. FMC is developing biological solutions which are unique to the marketplace and bring consistency in performance and higher yields.
The submission for these strains is for seed treatment, in-furrow and transplant application usages and the Company has filed petitions to establish exemptions from the requirement of tolerances. These submissions are anticipated to receive EPA approval in late 2020.
FMC previously received U.S. EPA registration for a Bacillus licheniformis strain FMCH001 and Bacillus subtilis strain FMCH002, as well as two associated formulated products, in May 2018.
Source: FMC Corporation
Southeast AgNet’s Randall Weiseman caught up with Kaustubh Borah, North America commercial manager and business development lead for plant health at FMC, to discuss these two strains and FMC’s vision for its growing biological lineup.